Molecular imaging analysis of intestinal insulin absorption boosted by cell-penetrating peptides by using positron emission tomography

Journal of Controlled Release

Volumn 146, Issue 1, 2010, Pages 16-22

  Kamei, Noriyasu ^a   Morishita Mariko, M ^a   Kanayama, Yousuke ^b   Hasegawa, Koki ^b   Nishimura, Mie ^b   Hayashinaka, Emi ^b   Wada, Yasuhiro ^b   Watanabe, Yasuyoshi ^b   Takayama, Kozo ^a  

^a HOSHI UNIVERSITY   (Japan)

^b RIKEN   (Japan)

Author keywords

Cell penetrating peptides; Insulin; Intestinal absorption; Molecular imaging; Positron emission tomography (PET)

Indexed keywords

CELL-PENETRATING PEPTIDE; CELL-PENETRATING PEPTIDES; CLOSED LOOPS; DRUG DELIVERY SYSTEM; IN-VIVO; INTESTINAL ABSORPTION; MOLECULAR IMAGING; NONINVASIVE TOOLS; PENETRATIN; PET IMAGING; THERAPEUTIC AGENTS;

ABSORPTION; DRUG DELIVERY; ELECTRONS; GALLIUM; IMAGING TECHNIQUES; INSULIN; LIVER; PEPTIDES; POSITRONS;

POSITRON EMISSION TOMOGRAPHY;

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID; CELL PENETRATING PEPTIDE; GALLIUM 68; INSULIN; PENETRATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG STRUCTURE; IMAGE ANALYSIS; INTESTINE ABSORPTION; MALE; MOLECULAR IMAGING; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RAT;

ANIMALS; CELL-PENETRATING PEPTIDES; DRUG CARRIERS; GADOLINIUM; HYPOGLYCEMIC AGENTS; ILEUM; INSULIN; INTESTINAL ABSORPTION; INTESTINES; MALE; MOLECULAR IMAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOISOTOPES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 77955269563     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2010.05.004     Document Type: Article

References (40)

1. Goldberg M., Gomez-Orellana I. Challenges for the oral delivery of macromolecules. Nat. Rev. Drug Discov. 2003, 2:289-295.
2. Owens D.R., Zinman B., Bolli G. Alternative routes of insulin delivery. Diabet. Med. 2003, 20:886-898.
3. Morishita M., Peppas N.A. Is the oral route possible for peptide and protein drug delivery?. Drug Discov. Today 2006, 11:905-910.
4. Khafagy El-S., Morishita M., Onuki Y., Takayama K. Current challenges in non-invasive insulin delivery systems: a comparative review. Adv. Drug Deliv. Rev. 2007, 59:1521-1546.
5. Yamamoto A., Taniguchi T., Rikyuu K., Tsuji T., Fujita T., Murakami M., Muranishi S. Effects of various protease inhibitors on the intestinal absorption and degradation of insulin in rats. Pharm. Res. 1994, 11:1496-1500.
6. Liu H., Tang R., Pan W.S., Zhang Y., Liu H. Potential utility of various protease inhibitors for improving the intestinal absorption of insulin in rats. J. Pharm. Pharmacol. 2003, 55:1523-1529.
7. Takeuchi H., Yamamoto H., Niwa T., Hino T., Kawashima Y. Enteral absorption of insulin in rats from mucoadhesive chitosan-coated liposomes. Pharm. Res. 1996, 13:896-901.
8. Takeuchi H., Matsui Y., Yamamoto H., Kawashima Y. Mucoadhesive properties of carbopol or chitosan-coated liposomes and their effectiveness in the oral administration of calcitonin to rats. J. Control. Release 2003, 86:235-242.
9. Degim Z., Unal N., Essiz D., Abbasoglu U. The effect of various liposome formulations on insulin penetration across Caco-2 cell monolayer. Life Sci. 2004, 75:2819-2827.
10. Nakamura K., Morishita M., Ehara J., Onuki Y., Yamagata T., Kamei N., Lowman A.M., Peppas N.A., Takayama K. Key functions in polymer carriers for intestinal absorption of insulin. Int. J. Pharm. 2008, 354:135-142.
11. Kamei N., Morishita M., Chiba H., Kavimandan N.J., Peppas N.A., Takayama K. Complexation hydrogels for intestinal delivery of interferon β and calcitonin. J. Control. Release 2009, 134:98-102.
12. Damgé C., Reis C.P., Maincent P. Nanoparticle strategies for the oral delivery of insulin. Expert Opin. Drug Deliv. 2008, 5:45-68.
13. Vives E., Brodin P., Lebleu B. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 1997, 272:16010-16017.
14. Futaki S. Oligoarginine vectors for intracellular delivery: design and cellular-uptake mechanisms. Biopolymers 2006, 84:241-249.
15. Nakase I., Takeuchi T., Tanaka G., Futaki S. Methodological and cellular aspects that govern the internalization mechanisms of arginine-rich cell-penetrating peptides. Adv. Drug Deliv. Rev. 2008, 60:598-607.
16. Futaki S., Suzuki T., Ohashi W., Yagami T., Tanaka S., Ueda K., Sugiura Y. Arginine-rich peptides. An abundant source ofmembrane-permeable peptides having potential as carriers for intracellular protein delivery. J. Biol. Chem. 2001, 276:5836-5840.
17. Mitchell D.J., Kim D.T., Steinman L., Fathman C.G., Rothbard J.B. Polyarginine enters cells more efficiently than other polycationic homopolymers. J. Pept. Res. 2000, 56:318-325.
18. Derossi D., Joliot A.H., Chassaing G., Prochiantz A. The third helix of the Antennapedia homeodomain translocates through biological membranes. J. Biol. Chem. 1994, 269:10444-10450.
19. Morishita M., Kamei N., Ehara J., Isowa K., Takayama K. A novel approach using functional peptides for efficient intestinal absorption. J. Control. Release 2007, 118:177-184.
20. Kamei N., Morishita M., Eda Y., Ida N., Nishio R., Takayama K. Usefulness of cell-penetrating peptides to improve intestinal insulin absorption. J. Control. Release 2008, 132:21-25.
21. Kamei N., Morishita M., Takayama K. Importance of intermolecular interaction on the improvement of intestinal therapeutic peptide/protein absorption using cell-penetrating peptides. J. Control. Release 2009, 136:179-186.
22. Ohira T., Okuma T., Matsuoka T., Wada Y., Nakamura K., Watanabe Y., Inoue Y. FDG-microPET and diffusion-weighted MR image evaluation of early changes after radiofrequency ablation in implanted VX2 tumors in rabbits. Cardiovasc. Interv. Radiol. 2009, 32:114-120.
23. Okuma T., Matsuoka T., Okamura T., Wada Y., Yamamoto A., Oyama Y., Koyama K., Nakamura K., Watanabe Y., Inoue Y. 18F-FDG small-animal PET for monitoring the therapeutic effect of CT-guided radiofrequency ablation on implanted VX2 lung tumors in rabbits. J. Nucl. Med. 2006, 47:1351-1358.
24. Cui Y., Takamatsu H., Kakiuchi T., Ohba H., Kataoka Y., Yokoyama C., Onoe H., Watanabe Y., Hosoya T., Suzuki M., Noyori R., Tsukada H., Watanabe Y. Neuroprotection by a central nervous system-type prostacyclin receptor ligand demonstrated in monkeys subjected to middle cerebral artery occlusion and reperfusion: a positron emission tomography study. Stroke 2006, 37:2830-2836.
25. Sasabe T., Kobayashi M., Kondo Y., Onoe H., Matsubara S., Yamamoto S., Tsukada H., Onoe K., Watabe H., Iida H., Kogo M., Sano K., Hatanaka A., Sawada T., Watanabe Y. Activation of the anterior cingulate gyrus by 'Green Odor': a positron emission tomography study in the monkey. Chem. Senses 2003, 28:565-572.
26. Kobayashi M., Sasabe T., Takeda M., Kondo Y., Yoshikubo S., Imamura K., Onoe H., Sawada T., Watanabe Y. Functional anatomy of chemical senses in the alert monkey revealed by positron emission tomography. Eur. J. Neurosci. 2002, 16:975-980.
27. 68Ga-DOTA-Somatostatin. Pept. Sci. 2008, 417-418.
28. 68Ga for medical application. J. Nucl. Med. 2007, 48:1741-1748.
29. Penicaud L., Ferre P., Kande J., Leturque A., Issad T., Girard J. Effect of anesthesia on glucose production and utilization in rats. Am. J. Physiol. 1987, 252:E365-E369.
30. Yamamoto A. Improvement of transmucosal absorption of biologically active peptide drugs. Yakugaku Zasshi 2001, 121:929-948.
31. Gotoh S., Nakamura R., Nishiyama M., Quan Y.S., Fujita T., Yamamoto A., Muranishi S. Effects of protease inhibitors on the absorption of phenol red and fluorescein isothiocyanate dextrans from the rat intestine. J. Pharm. Sci. 1996, 85:858-862.
32. Schwarze S.R., Ho A., Vocero-Akbani A., Dowdy S.F. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 1999, 285:1569-1572.
33. Astriab-Fisher A., Sergueev D., Fisher M., Shaw B.R., Juliano R.L. Conjugates of antisense oligonucleotides with the TAT and antennapedia cell-penetrating peptides: effects on cellular uptake, binding to target sequences, and biologic actions. Pharm. Res. 2002, 19:744-754.
34. Torchilin V.P., Levchenko T.S. TAT-liposomes: a novel intracellular drug carrier. Curr. Protein Pept. Sci. 2003, 4:133-140.
35. Marty C., Meylan C., Schott H., Ballmer-Hofer K., Schwendener R.A. Enhanced heparan sulfate proteoglycan-mediated uptake of cell-penetrating peptide-modified liposomes. Cell Mol. Life Sci. 2004, 61:1785-1794.
36. Gupta B., Levchenko T.S., Torchilin V.P. Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides. Adv. Drug Deliv. Rev. 2005, 57:637-651.
37. Swanson J.A., Watts C. Macropinocytosis, trends. Cell Biol. 1995, 5:424-428.
38. Falcone S., Cocucci E., Podini P., Kirchhausen T., Clementi E., Meldolesi J. Macropinocytosis: regulated coordination of endocytic and exocytic membrane traffic events. J. Cell Sci. 2006, 119:4758-4769.
39. Kamei N., Morishita M., Ehara J., Takayama K. Permeation characteristics of oligoarginine through intestinal epithelium and its usefulness for intestinal peptide drug delivery. J. Control. Release 2008, 131:94-99.
40. Duckworth W.C., Bennett R.G., Hamel F.G. Insulin degradation: progress and potential. Endocr. Rev. 1998, 19:608-624.